JHS Svendgaard Laboratories Limited (BOM:532771)
India · Delayed Price · Currency is INR 10.36
-0.48 (-4.43%)
At close: Feb 13, 2026
BOM:532771 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 941.72 | 919.97 | 707.98 | 848.15 | 862.52 | 1,008 |
Other Revenue | 15.61 | 2.94 | 20.95 | 63.45 | 9.59 | 2.05 |
Revenue | 957.33 | 922.91 | 728.93 | 911.59 | 872.11 | 1,010 |
Revenue Growth (YoY) | 7.45% | 26.61% | -20.04% | 4.53% | -13.63% | -28.72% |
Cost of Revenue | 626.53 | 637.86 | 458.54 | 631.4 | 620.72 | 705.19 |
Gross Profit | 330.8 | 285.05 | 270.4 | 280.2 | 251.39 | 304.51 |
Selling, General & Admin | 107.94 | 105.06 | 97.64 | 120.49 | 117.54 | 107.38 |
Other Operating Expenses | 210.67 | 209.25 | 154.71 | 186.44 | 105.2 | 121.02 |
Operating Expenses | 395.23 | 393.81 | 315.81 | 367.1 | 293.26 | 300.95 |
Operating Income | -64.43 | -108.75 | -45.42 | -86.9 | -41.87 | 3.55 |
Interest Expense | -7.55 | -4.72 | -4.25 | -4.98 | -12.7 | -12.4 |
Interest & Investment Income | 12.24 | 12.24 | 5.61 | 9.9 | 21.99 | 8.3 |
Currency Exchange Gain (Loss) | 0.04 | 0.04 | -1.2 | 9 | 6.53 | -7.35 |
Other Non Operating Income (Expenses) | 0.48 | 0.48 | 1.15 | 133.33 | 5.15 | 16.08 |
EBT Excluding Unusual Items | -59.22 | -100.71 | -44.1 | 60.35 | -20.9 | 8.18 |
Gain (Loss) on Sale of Investments | 3.63 | 3.63 | 2.85 | 0.7 | 1.53 | 2 |
Gain (Loss) on Sale of Assets | 0.59 | 0.59 | 0.02 | 25.4 | 15 | -0.5 |
Other Unusual Items | -28.59 | -28.59 | 6.95 | -183.62 | 5.4 | - |
Pretax Income | -83.59 | -125.08 | -34.29 | -97.18 | 1.03 | 9.68 |
Income Tax Expense | -30.46 | 72.37 | 6.29 | -54.28 | 43.92 | -3.75 |
Earnings From Continuing Operations | -53.13 | -197.44 | -40.58 | -42.89 | -42.89 | 13.42 |
Minority Interest in Earnings | - | - | - | 2.37 | 2.37 | -1.44 |
Net Income | -53.13 | -197.44 | -40.58 | -40.52 | -40.52 | 11.98 |
Net Income to Common | -53.13 | -197.44 | -40.58 | -40.52 | -40.52 | 11.98 |
Shares Outstanding (Basic) | 86 | 83 | 78 | 78 | 64 | 61 |
Shares Outstanding (Diluted) | 86 | 83 | 78 | 78 | 64 | 62 |
Shares Change (YoY) | 6.21% | 6.07% | - | 21.89% | 4.34% | 1.22% |
EPS (Basic) | -0.62 | -2.37 | -0.52 | -0.52 | -0.63 | 0.20 |
EPS (Diluted) | -0.62 | -2.37 | -0.52 | -0.52 | -0.63 | 0.20 |
Free Cash Flow | - | -157.11 | -407.1 | 89.43 | -158.75 | 36.96 |
Free Cash Flow Per Share | - | -1.89 | -5.19 | 1.14 | -2.47 | 0.60 |
Gross Margin | 34.55% | 30.89% | 37.09% | 30.74% | 28.83% | 30.16% |
Operating Margin | -6.73% | -11.78% | -6.23% | -9.53% | -4.80% | 0.35% |
Profit Margin | -5.55% | -21.39% | -5.57% | -4.45% | -4.65% | 1.19% |
Free Cash Flow Margin | - | -17.02% | -55.85% | 9.81% | -18.20% | 3.66% |
EBITDA | 19.8 | -35.67 | 12.81 | -26.74 | 28.65 | 60.52 |
EBITDA Margin | 2.07% | -3.86% | 1.76% | -2.93% | 3.28% | 5.99% |
D&A For EBITDA | 84.23 | 73.08 | 58.22 | 60.17 | 70.52 | 56.96 |
EBIT | -64.43 | -108.75 | -45.42 | -86.9 | -41.87 | 3.55 |
EBIT Margin | -6.73% | -11.78% | -6.23% | -9.53% | -4.80% | 0.35% |
Effective Tax Rate | - | - | - | - | 4264.47% | - |
Revenue as Reported | 983.16 | 948.74 | 751.13 | 961.36 | 956.42 | 1,083 |
Advertising Expenses | - | 3.4 | 2.85 | 17.79 | 2.44 | 2.72 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.